Molecular evidences on the benefit of N-acetylcysteine in experimental colitis

Central European Journal of Biology

Volumn 3, Issue 2, 2008, Pages 135-142

  Ebrahimi, Fatemeh ^a   Esmaily, Hadi ^a   Baeeri, Maryam ^a   Mohammadirad, Azadeh ^a   Fallah, Saeed ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DSS (dextran sodium sulfate; IBD (inflammatory bowel disease); Lipid peroxidation; NAC (N acetylcysteine); Oxidative stress

Indexed keywords

ANIMALIA; MUS;

EID: 43349085864     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-008-0005-x     Document Type: Article

References (52)

1. Simmonds N.J., Rampton D.S., Inflammatory bowel disease-a radical view, Gut, 1993, 34, 865-868
2. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al., Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease, Dig. Dis. Sci. 1996, 41, 2078-2086
3. Elahi B., Nikfar S., Derakhshani S., Vafaie M., Abdollahi M., On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: A meta-analysis of controlled clinical trials, Dig. Dis. Sci., 2007, 17, [Epub ahead of print]
4. Rezaie A., Parker R.D., Abdollahi M, Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?, Dig. Dis. Sci., 2007, 52, 2015-2021
5. Rahimi R., Nikfar S., Rezaie A., Abdollahi M., A meta-analysis of antibiotic therapy for active ulcerative colitis, Dig. Dis. Sci., 2007, 52, 2920-2925
6. Rahimi R., Nikfar S., Rezaie A., Abdollahi M., A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease, Clin. Ther., 2006, 28, 1983-1988
7. Rezaie A., Taghavi-Bayat B., Abdollahi M., Biologic management of fistulizing Crohn's disease., Int. J. Pharmacol., 2005, 1, 17-24
8. Nakhai L.A., Mohammadirad A., Yasa N., Minaie B., Nikfar S., Ghazanfari G., et al., Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease, Evid. Based Complement. Alternat. Med., 2007, 4, 43-50
9. Ghafari H., Yasa N., Mohammadirad A., Dehghan G., Zamani M.J., Nikfar S., et al., Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity, Hum. Exp. Toxicol., 2006, 25, 325-332
10. Ghazanfari G., Minaie B., Yasa N., Ashtaral-Nakhai L., Mohammadirad A., Nikfar S., et al., Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases, Toxicol. Mech. Methods, 2006, 16, 365-372
11. Khoshakhlagh P., Bahrololoumi-Shapourabadi B., Mohammadirad A., Ashtaral-Nakhai L., Minaie B., Abdollahi M., Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress, Toxicol. Mech. Methods, 2007, 17, 281-288
12. Jahanshahi G., Motavasel V., Rezaie A., Hashtroudi A.A., Daryani N.E., Abdollahi M., Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases, Dig. Dis. Sci., 2004, 49, 1752-1757
13. D'Odorico A., Bortolan S., Cardin R., D'Inca' R., Martines D., Ferronato A., et al., Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease, Scand. J. Gastroenterol., 2001, 36, 1289-1294
14. Gross S.S., Wolin M.S., Nitric oxide: pathophysiological mechanisms, Annu. Rev. Physiol., 1995, 57, 737-769
15. Naito Y., Takagi T., Ishikawa T., Handa O., Matsumoto N., Yagi N., et al., The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice, Eur. J. Pharmacol., 2001, 412, 91-99
16. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., et al., Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease, Gastroenterology, 1996, 111, 871-885
17. Rezaie A., Khalaj S., Shabihkhani M., Nikfar S., Zamani M.J., Mohammadirad A., et al., Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients, Ann. N. Y. Acad. Sci., 2007, 1095, 305-314
18. Rezaie A., Ghorbani F., Eshghtork A., Zamani M.J., Dehghan G., Taghavi B., et al., Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to disease activity in Crohn's disease patients, Ann. N. Y. Acad. Sci., 2006, 1091,110-122
19. Rahimi R., Nikfar S., Abdollahi M., Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials, Biomed. Pharmacother., 2007, 61, 75-80
20. Rahimi R., Nikfar S., Abdollahi M., Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids, Med. Sci. Monit., 2007, 13, PI13-PI18
21. Yoshida N., Yoshikawa T., Yamaguchi T., Naito Y., Tanigawa T., Murase H., et al., A novel water-soluble vitamin E derivative protects against experimental colitis in rats, Antioxid. Redox. Signal., 1999, 1, 555-562
22. Ademoglu E., Erbil Y., Tam B., Barbaros U., Ilhan E., Olgac V., et al., Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis, Dig. Dis. Sci., 2004, 49, 102-108
23. Sadegh Soltan-Sharifi M., Mojtahedzadeh M., Najafi A., Khajavi M.R., Rouini M.R., Moradi M., et al., Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms, Hum. Exp. Toxicol., 2007, 26, 697-703
24. Shadnia S., Dasgar M., Taghikhani S., Mohammadirad A., Khorasani R., Abdollahi M., Protective effects of alpha-tocopherol and N-acetyl-cysteine on diazinon-induced oxidative stress and acetylcholinesterase inhibition in rats, Toxicol. Mech. Methods, 2007, 17, 109-115
25. Zamani M.J., Sharifzadeh M., Rezaie R., Mashayekhi F., Abdollahi M., Effects of sildenafil on rat irritable bowel syndrome, Therapy, 2005, 2, 237-242
26. Osman N., Adawi D., Ahrne S., Jeppsson B., Molin G., Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium, Dig. Dis. Sci., 2004, 49, 320-327
27. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J., Clinicopathologic study of dextran sulfate sodium experimental murine colitis, Lab. Invest., 1993, 69, 238-249
28. Benzie I.F., Strain J.J., Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration, Methods Enzymol., 1999, 299, 15-27
29. Ranjbar A., Pasalar P., Abdollahi M., Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers, Hum. Exp. Toxicol., 2002, 21, 179-182
30. Satoh K., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method, Clin. Chim. Acta, 1978, 90, 37-43
31. Aebi H., Catalase in vitro, Methods Enzymol., 1984, 105, 121-126
32. Ukeda H., Maeda S., Ishii T., Sawamura M., Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3'-1-(phenylamino)-carbonyl-3, 4-tetrazolium]-bis(4-methoxy-6-nitro) benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase, Anal. Biochem., 1997, 251, 206-209
33. Stepaniak J.A., Gould K.E., Sun D., Swanborg R.H., A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats, J. Immunol., 1995, 155, 2762-2769
34. Guevara I., Iwanejko J., Dembińska-Kieć A., Pankiewicz J., Wanat A., Anna P., et al., Determination of nitrite/nitrate in human biological material by the simple Griess reaction, Clin. Chim. Acta, 1998, 274, 177-188
35. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 1951, 193, 265-275
36. De Vries N., De Flora S., N-acetyl-l-cysteine, J. Cell Biochem. Suppl., 1993, 17F, 270-277
37. Grisham M.B., Oxidants and free radicals in inflammatory bowel disease, Lancet, 1994, 344, 859-861
38. Aydin S., Ozaras R., Uzun H., Belce A., Uslu E., Tahan V., et al., N-acetylcysteine reduced the effect of ethanol on antioxidant system in rat plasma and brain tissue, Tohoku J. Exp. Med., 2002, 198, 71-77
39. Park E.S., Kim S.D., Lee M.H., Lee H.S., Lee I.S., Sung J.K., et al., Protective effects of N-acetylcysteine and selenium against doxorubicin toxicity in rats, J. Vet. Sci., 2003, 4, 129-136
40. Tüzün A., Erdil A., Inal V., Aydin A., Baǧci S., Yeşilova Z., et al., Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease, Clin. Biochem., 2002, 35, 569-572
41. Szabo S., Gallagher G.T., Silver E.H., Maull E.A., Horner H.C., Komanicky P., et al., Subacute and chronic action of acrylonitrile on adrenals and gastrointestinal tract: biochemical, functional and ultrastructural studies in the rat, J. Appl. Toxicol., 1984, 4, 131-140
42. Satoh H., Sato F., Takami K., Szabo S., New ulcerative colitis model induced by sulfhydryl blockers in rats and the effects of antiinflammatory drugs on the colitis, Jpn. J. Pharmacol., 1997, 73, 299-309
43. Seguí J., Gironella M., Sans M., Granell S., Gil F., Gimeno M., et al., Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine, J. Leukoc. Biol., 2004, 76, 537-544
44. Kuralay F., Yildiz C., Ozutemiz O., Islekel H., Caliskan S., Bingol B., et al., Effects of trimetazidine on acetic acid-induced colitis in female Swiss rats, J. Toxicol. Environ. Health A., 2003, 66, 169-179
45. Beno I., Staruchová M., Bátovský M., Volkovová K., Adenomatous and inflammatory colorectal polyps: antioxidative enzyme activity in the colon, Cas. Lek. Cesk., 1996, 135, 208-210
46. Cetinkaya A., Bulbuloglu E., Kurutas E.B., Ciralik H., Kantarceken B., Buyukbese M.A., Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats, Tohoku J. Exp. Med., 2005, 206, 131-139
47. Liu S.P., Dong W.G., Wu D.F., Luo H.S., Yu J.P., Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats, World J. Gastroenterol., 2003, 9, 2786-2790
48. Bergamini S., Rota C., Canali R., Staffieri M., Daneri F., Bini A., et al., N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase, Nitric Oxide, 2001, 5, 349-360
49. Boughton-Smith N.K., Evans S.M., Hawkey C.J., Cole A.T., Balsitis M., Whittle B.J., et al., Nitric oxide synthase activity in ulcerative colitis and Crohn's disease, Lancet, 1993, 342, 338-340
50. Colón A.L., Menchén L., Lizasoain I., Leza J.C., Menchén P., González-Lara V., et al., Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker, Am. J. Gastroenterol., 2000, 95, 1371-1373
51. Akgun E., Caliskan C., Celik H.A., Ozutemiz A.O., Tuncyurek M., Aydin H.H., Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats, J. Int. Med. Res., 2005, 33, 196-206
52. Naito Y., Takagi T., Uchiyama K., Kuroda M., Kokura S., Ichikawa H., et al., Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice, Int. J. Mol. Med., 2004, 14, 191-196